| Literature DB >> 19269520 |
Phil Quirke1, Robert Steele, John Monson, Robert Grieve, Subhash Khanna, Jean Couture, Chris O'Callaghan, Arthur Sun Myint, Eric Bessell, Lindsay C Thompson, Mahesh Parmar, Richard J Stephens, David Sebag-Montefiore.
Abstract
BACKGROUND: Local recurrence rates in operable rectal cancer are improved by radiotherapy (with or without chemotherapy) and surgical techniques such as total mesorectal excision. However, the contributions of surgery and radiotherapy to outcomes are unclear. We assessed the effect of the involvement of the circumferential resection margin and the plane of surgery achieved.Entities:
Mesh:
Year: 2009 PMID: 19269520 PMCID: PMC2668948 DOI: 10.1016/S0140-6736(09)60485-2
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321
Factors associated with plane of surgery achieved
| Sex | ||||
| Male | 109 (71%) | 272 (68%) | 454 (75%) | |
| Female | 45 (29%) | 126 (32%) | 150 (25%) | |
| Age | ||||
| ≤54 | 21 (14%) | 56 (14%) | 107 (18%) | |
| 55–64 | 39 (25%) | 127 (32%) | 197 (33%) | |
| 65–74 | 64 (42%) | 158 (40%) | 227 (38%) | |
| ≥75 | 30 (19%) | 57 (14%) | 73 (12%) | |
| Treatment | ||||
| Preoperative radiotherapy | 65 (42%) | 196 (49%) | 303 (50%) | |
| Selective postoperative chemoradiotherapy | 89 (58%) | 202 (51%) | 301 (50%) | |
| Distance of distal tumour extent from anal verge | ||||
| >10–15 cm | 19 (12%) | 54 (14%) | 100 (17%) | |
| >5–10 cm | 71 (46%) | 176 (45%) | 336 (56%) | |
| 0–5 cm | 63 (41%) | 164 (42%) | 163 (27%) | |
| Missing | 1 | 4 | 5 | |
| Operation | ||||
| Anterior resection | 69 (48%) | 224 (58%) | 407 (71%) | |
| Abdominoperineal excision | 70 (48%) | 152 (39%) | 134 (24%) | |
| Hartmann's | 5 (3%) | 6 (2%) | 20 (4%) | |
| Other | 1 (1%) | 5 (1%) | 9 (2%) | |
| Missing | 9 | 11 | 34 | |
| CRM | ||||
| Positive | 29 (19%) | 47 (12%) | 52 (9%) | |
| Negative | 123 (81%) | 347 (88%) | 543 (91%) | |
| Missing | 2 | 4 | 9 | |
| TNM stage | ||||
| I | 44 (29%) | 95 (24%) | 164 (27%) | |
| II | 41 (27%) | 126 (32%) | 182 (30%) | |
| III | 67 (44%) | 172 (43%) | 250 (41%) | |
| IV | 1 (1%) | 4 (1%) | 7 (1%) | |
| Missing | 1 | 1 | 1 | |
CRM=circumferential resection margin.
Figure 1Circumferential resection margin positivity rate during trial recruitment
Figure 2Effect of treatment on circumferential resection margin and plane of surgery subgroups
CRM=circumferential resection margin. HR=hazard ratio. +ve=positive. −ve=negative.
Figure 3Plane of surgery achieved during trial recruitment
3-year local recurrence rates for the plane of surgery achieved
| Overall | 13% | 7%, 0·48 (0·25–0·93) | 4%, 0·32 (0·16–0·64) | |
| Treatment | ||||
| Preoperative radiotherapy | 10% | 4%, 0·52 (0·15–1·79) | 1%, 0·09 (0·02–0·49) | |
| Selective postoperative chemoradiotherapy | 16% | 10%, 0·49 (0·23–1·06) | 7%, 0·48 (0·23–1·00) | |
| Sex | ||||
| Male | 12% | 9%, 0·57 (0·27–1·22) | 4%, 0·28 (0·12–0·67) | |
| Female | 18% | 5%, 0·36 (0·10–1·23) | 4%, 0·35 (0·10–1·19) | |
| Age | ||||
| ≤54 | 18% | 9%, 0·22 (0·04–1·16) | 4%, 0·17 (0·03–0·93) | |
| 55–64 | 13% | 9%, 0·51 (0·15–1·73) | 5%, 0·22 (0·05–0·92) | |
| 65–74 | 15% | 7%,0·56 (0·20–1·59) | 4%, 0·40 (0·13–1·18) | |
| ≥75 | 7% | 4%, 0·37 (0·06–2·29) | 5%, 0·63 (0·13–3·11) | |
| Operation | ||||
| Anterior resection | 11% | 7%, 0·62 (0·21–1·79) | 5%, 0·58 (0·20–1·65) | |
| Abdominoperineal excision | 18% | 10%, 0·41 (0·18–0·93) | 3%, 0·18 (0·07–0·47) | |
| CRM | ||||
| Positive | 21% | 13%, 0·67 (0·19–2·38) | 12%, 0·46 (0·12–1·76) | |
| Negative | 12% | 7%, 0·50 (0·24–1·06) | 4%, 0·33 (0·15–0·74) | |
| TNM stage | ||||
| I | 8% | 2%, 0·33 (0·07–1·59) | 0%, 0·01 (0·00–0·10) | |
| II | 6% | 2%, 0·11 (0·01–0·94) | 5%, 0·78 (0·20–3·08) | |
| III | 20% | 14%, 0·72 (0·33–1·56) | 6%, 0·37 (0·15–0·89) | |
Compared with muscularis propria. CRM=circumferential resection margin. HR=hazard ratio.
Figure 5Effect of circumferential resection margin on local recurrence and disease-free survival in different planes of surgery achieved
3-year disease-free survival rates for plane of surgery achieved
| Overall | 70% | 75%, 0·82 (0·57–1·19) | 79%, 0·76 (0·53–1·09) | |
| Treatment | ||||
| Preoperative radiotherapy | 71% | 76%, 0·83 (0·48–1·44) | 82%, 0·55 (0·30–1·01) | |
| Selective postoperative chemoradiotherapy | 70% | 74%, 0·81 (0·50–1·32) | 76%, 0·94 (0·60–1·46) | |
| Sex | ||||
| Male | 68% | 73%, 0·83 (0·54–1·26) | 80%, 0·63 (0·41–0·98) | |
| Female | 75% | 79%, 0·90 (0·44–1·84) | 75%, 0·98 (0·51–1·87) | |
| Age | ||||
| ≤54 | 71% | 72%, 0·88 (0·36–2·16) | 84%, 0·43 (0·15–1·24) | |
| 55–64 | 70% | 80%, 0·65 (0·31–1·37) | 78%, 0·75 (0·38–1·50) | |
| 65–74 | 69% | 75%, 0·97 (0·54–1·74) | 76%, 1·02 (0·59–1·76) | |
| ≥75 | 69% | 74%, 0·87 (0·40–2·04) | 83%, 0·64 (0·30–1·53) | |
| Operation | ||||
| Anterior resection | 69% | 77%, 0·89 (0·51–1·57) | 79%, 0·85 (0·49–1·47) | |
| Abdominoperineal excision | 71% | 74%, 0·74 (0·44–1·25) | 83%, 0·53 (0·30–0·95) | |
| CRM | ||||
| positive | 51% | 49%, 1·05 (0·55–1·99) | 55%, 0·83 (0·43–1·62) | |
| negative | 74% | 78%, 0·87 (0·56–1·35) | 81%, 0·84 (0·55–1·28) | |
| TNM stage | ||||
| I | 88% | 93%, 0·60 (0·19–1·92) | 95%, 0·29 (0·08–1·04) | |
| II | 66% | 83%, 0·36 (0·16–0·80) | 82%, 0·51 (0·25–1·05) | |
| III | 63% | 62%, 1·12 (0·71–1·78) | 68%, 0·97 (0·61–1·54) | |
Compared with muscularis propria. CRM=circumferential resection margin. DFS=disease-free survival. HR=hazard ratio.
Factors associated with local recurrence
| N stage (0, 1, 2) | 1·78 (1·32–2·42) | <0·0001 | |
| Treatment | |||
| Preoperative radiotherapy | 1·00 | .. | |
| Selective postoperative chemoradiotherapy | 2·45 (1·45–4·17) | 0·001 | |
| T stage (1, 2, 3, 4) | 1·71 (1·11–2·63) | 0·02 | |
| Tumour involving anterior quadrant | |||
| No | 1·00 | .. | |
| Yes | 1·85 (1·04–3·27) | 0·04 | |
| Plane of surgery | 1·37 (1·00–1·89) | 0·05 | |
HR=hazard ratio. N=nodes. T=tumour.